REGENXBIO Inc. (RGNX)

REGENXBIO Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	57.53	34.52	96.95	345.21	338.43
Short-Term Investments	177.16	240.74	267.69	112.23	137.31
Cash & Short-Term Investments	234.69	275.26	364.64	457.44	475.74
Cash Growth	-14.74%	-24.51%	-20.29%	-3.85%	60.61%
Accounts Receivable	20.47	24.79	28.08	28.51	43.35
Other Receivables	12.4	19.3	8.5	-	-
Receivables	32.87	44.09	36.59	28.51	43.35
Prepaid Expenses	9.07	14.52	13.9	18.75	10.51
Other Current Assets	1.38	1.11	0.85	14.12	1.6
Total Current Assets	278	334.97	415.98	518.83	531.2
Property, Plant & Equipment	171.31	192.59	206.8	192.45	120.28
Long-Term Investments	10.18	38.87	200.56	391.91	47.91
Long-Term Accounts Receivable	0.47	0.7	1.5	2.26	3.27
Other Long-Term Assets	6.03	6.84	8.43	8.46	5.51
Total Assets	465.99	573.97	833.27	1,114	708.16
Accounts Payable	22.8	22.79	27.21	11.39	10.62
Accrued Expenses	37.91	49.32	45.99	59.5	38.09
Current Portion of Long-Term Debt	34.31	50.57	48.6	37.89	18.79
Current Portion of Leases	7.9	7.07	6	1.75	2.5
Current Income Taxes Payable	-	-	-	11.33	3.14
Current Unearned Revenue	0.12	0.15	1.83	3.33	0.45
Other Current Liabilities	0.16	0.39	0.81	5.29	7.85
Total Current Liabilities	103.19	130.27	130.43	130.47	81.45
Long-Term Debt	25.38	43.49	89.01	133.46	174.5
Long-Term Leases	74.13	82.22	88.8	84.93	70.15
Long-Term Unearned Revenue	-	-	-	-	3.78
Other Long-Term Liabilities	3.64	6.25	8.83	0.75	0.52
Total Liabilities	206.34	262.23	317.07	349.61	330.41
Common Stock	0.01	0	0	0	0
Additional Paid-In Capital	1,193	1,021	973.15	928.1	667.18
Retained Earnings	-932.15	-705.05	-441.55	-161.23	-289.07
Comprehensive Income & Other	-0.74	-4.43	-15.4	-2.57	-0.36
Total Common Equity	259.65	311.74	516.2	764.3	377.75
Shareholders' Equity	259.65	311.74	516.2	764.3	377.75
Total Liabilities & Equity	465.99	573.97	833.27	1,114	708.16
Total Debt	141.72	183.34	232.41	258.03	265.95
Net Cash (Debt)	103.15	130.79	332.8	591.32	256.6
Net Cash Growth	-21.13%	-60.70%	-43.72%	130.45%	-33.99%
Net Cash Per Share	2.08	2.99	7.71	13.47	6.88
Filing Date Shares Outstanding	50.09	44.43	43.46	42.95	42.5
Total Common Shares Outstanding	49.55	44.05	43.3	42.83	37.48
Working Capital	174.81	204.7	285.54	388.35	449.75
Book Value Per Share	5.24	7.08	11.92	17.84	10.08
Tangible Book Value	259.65	311.74	516.2	764.3	377.75
Tangible Book Value Per Share	5.24	7.08	11.92	17.84	10.08
Machinery	88.42	87.38	83.68	68.05	34.18
Leasehold Improvements	101.47	101.93	99.4	92.54	44.96

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q